(-0.88%) 4 967.23 points
(0.56%) 37 986 points
(-2.05%) 15 282 points
(0.62%) $83.24
(0.17%) $1.760
(0.36%) $2 406.70
(1.29%) $28.75
(-1.17%) $943.30
(-0.14%) $0.938
(-0.28%) $11.01
(0.55%) $0.808
(-0.96%) $93.00
Live Chart Being Loaded With Signals
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas...
Stats | |
---|---|
Today's Volume | 1.06M |
Average Volume | 1.49M |
Market Cap | 1.67B |
EPS | $0 ( 2024-03-01 ) |
Next earnings date | ( $0.0900 ) 2024-05-03 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -11.29 |
ATR14 | $0.00700 (0.13%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-12 | Konidaris Tasos | Buy | 87 720 | Class A Common Stock |
2024-03-12 | Konidaris Tasos | Sell | 30 790 | Class A Common Stock |
2024-03-12 | Konidaris Tasos | Sell | 87 720 | Restricted Stock Units |
2024-03-04 | Patel Chintu | Buy | 1 333 334 | Performance-Based Restricted Stock Units |
2024-03-04 | Patel Chintu | Buy | 370 370 | Restricted Stock Units |
INSIDER POWER |
---|
-8.44 |
Last 100 transactions |
Buy: 156 072 909 | Sell: 179 177 567 |
Volume Correlation
Amneal Pharmaceuticals Correlation
10 Most Positive Correlations | |
---|---|
ANAC | 0.962 |
AAC | 0.961 |
ESM-UN | 0.959 |
FTEV | 0.957 |
ACDI | 0.956 |
CPUH | 0.952 |
LII | 0.952 |
DMYS | 0.951 |
RCFA | 0.951 |
BCSF | 0.947 |
10 Most Negative Correlations | |
---|---|
TU | -0.951 |
WEI | -0.95 |
NJR | -0.947 |
BCE | -0.945 |
WDH | -0.944 |
TLK | -0.944 |
NUS | -0.941 |
AHT-PD | -0.94 |
TIXT | -0.938 |
DTLA-P | -0.935 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Amneal Pharmaceuticals Correlation - Currency/Commodity
Amneal Pharmaceuticals Financials
Annual | 2023 |
Revenue: | $2.39B |
Gross Profit: | $820.57M (34.28 %) |
EPS: | $-0.480 |
Q4 | 2023 |
Revenue: | $616.98M |
Gross Profit: | $189.83M (30.77 %) |
EPS: | $-0.400 |
Q3 | 2023 |
Revenue: | $620.04M |
Gross Profit: | $232.53M (37.50 %) |
EPS: | $0.0600 |
Q2 | 2023 |
Revenue: | $599.05M |
Gross Profit: | $220.02M (36.73 %) |
EPS: | $0.0800 |
Financial Reports:
No articles found.
Amneal Pharmaceuticals
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals across a range of therapeutic categories. The Specialty segment is involved in the development, promotion, distribution, and sale of branded pharmaceutical products with focus on central nervous system disorders, endocrinology, parasitic infections, and other therapeutic areas. It also offers Emverm, a chewable tablet for the treatment of pinworm, whipworm, common roundworm, common hookworm, and American hookworm in single or mixed infections; Rytary to treat Parkinson's disease; and Unithroid for the treatment of hypothyroidism. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies, the Department of Defense, and the Department of Veterans Affairs. It is also involved in the wholesale distribution of bottle and unit dose pharmaceuticals under the AvKARE and AvPAK names, as well as medical and surgical products; and packaging and wholesale distribution of pharmaceuticals and vitamins to its retail and institutional customers. The company sells its products through wholesalers, distributors, hospitals, chain pharmacies, and individual pharmacies. It operates in the United States, India, Ireland, and internationally. The company was formerly known as Atlas Holdings, Inc. and changed its name to Amneal Pharmaceuticals, Inc. in 2018. Amneal Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Bridgewater, New Jersey.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators